Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria

BACKGROUND: The 8-aminoquinoline antimalarials, the only drugs which prevent relapse of vivax and ovale malaria (radical cure), cause dose-dependent oxidant haemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Patients with <30% and <70% of normal G6PD activity a...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, James, Taylor, Walter R. J., Bancone, Germana, Chu, Cindy S., Jittamala, Podjanee, White, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931686/
https://www.ncbi.nlm.nih.gov/pubmed/29677199
http://dx.doi.org/10.1371/journal.pntd.0006440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931686/
https://www.ncbi.nlm.nih.gov/pubmed/29677199
http://dx.doi.org/10.1371/journal.pntd.0006440

Ejemplares similares